National Institute on Drug Abuse; Amended Notice of Meeting, 3980 [08-221]
Download as PDF
<![CDATA[
3980
Federal Register / Vol. 73, No. 15 / Wednesday, January 23, 2008 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Chronic
Fatigue and Fibromyalgia Syndromes,
Temporomandibular Disorders.
Date: February 22, 2008.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: J. Terrell Hoffeld, DDS,
PhD, Dental Officer, USPHS, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7816, Bethesda, MD 20892, 301–435–
1781, th88q@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, DNA Repair
and Carcinogenesis.
Date: February 26, 2006.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Denise R. Shaw, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawkath@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphsis Panel, Pilot and
Feasibility Clinical Studies in Digestive
Diseases and Nutrition.
Date: February 27, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Peter J. Perrin, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–224 Filed 1–22–08; 8:45 am]
BILLING CODE 4140–01–M
ebenthall on PROD1PC69 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Macromolecular
VerDate Aug<31>2005
18:31 Jan 22, 2008
Jkt 214001
Structure and Function D Study
Section, February 7, 2008, 8 a.m. to
February 8, 2008, 6 p.m., Hilton Long
Beach & Executive Meeting Center, 701
West Ocean Boulevard, Long Beach, CA,
90831 which was published in the
Federal Register on January 9, 2008, 73
FR 1637–1639.
The meeting will be held one day
only February 7, 2008, from 8 a.m. to 6
p.m. The meeting location remains the
same. The meeting is closed to the
public.
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–225 Filed 1–22–08; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendex 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals assocaited with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Clinical Investigator Awards (K08s).
Date: January 29, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: David A. Wilson, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7204, Bethesda, MD 20892–7924, 301–435–
0299, wilsonda2@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–220 Filed 1–22–08: 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Drug Abuse Special Emphasis Panel,
February 1, 2008, 1 p.m. to February 1,
2008, 5 p.m., National Institutes of
Health, 6101 Executive Boulevard,
Rockville, MD 20852 which was
published in the Federal Register on
January 9, 2008, Volume 73, Number 6.
The date of the meeting was changed
to February 22, 2008. The meeting is
closed to the public.
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–221 Filed 1–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDAL New Investigator R01 SEP.
Date: February 21, 2008.
Time: 12:30 p.m. to 3 p.m.
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 73, Number 15 (Wednesday, January 23, 2008)]
[Notices]
[Page 3980]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-221]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute on Drug Abuse Special Emphasis Panel, February 1, 2008, 1
p.m. to February 1, 2008, 5 p.m., National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852 which was published in the
Federal Register on January 9, 2008, Volume 73, Number 6.
The date of the meeting was changed to February 22, 2008. The
meeting is closed to the public.
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-221 Filed 1-22-08; 8:45 am]
BILLING CODE 4140-01-M
